Skip to main content
Equibles
KURA logo

KURA · Kura Oncology, Inc. · Metrics

Track KURA — free

Use KURA with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research KURA.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$9.98 +0.62 (+6.62%) At close · Oct 20
Russell 2000 member Rebalance outlook locked
Market Cap
$832.67M
Shares
88.96M
Volume · Oct 20 1.54M Avg daily vol (3M) 1.84M

KURA metrics

82 of 122 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$9.98
Market cap
$832.67M

Price action

20 metrics
Price change (1W)
-10.0%
Price change (30D)
-19.3%
Price change (3M)
-12.4%
Price change (6M)
-4.3%
Price change (YTD)
-9.9%
Price change (1Y)
-4.9%
Trailing year
Price change (5Y)
-47.2%
52-week high
$13.59
52-week low
$7.40
Change from 52-week high
-31.1%
Change from 52-week low
+26.5%
Annualized volatility
58.7%
Annualized volatility (3M)
55.4%
Beta
1.5
RSI (14D)
30.9
Price vs SMA 50
-17.3%
Price vs SMA 200
-4.3%
Avg volume (3M)
1.83M
Relative volume
1.2
Average dollar volume
$20.49M

Company

3 metrics
Sector
Healthcare
Industry
Biotechnology
Shares outstanding
88.96M

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
10.0×
reciprocal yield 10.0%
EV / EBITDA
—
EV / EBIT
—
P / sales
10.8×
reciprocal yield 9.3%
P / book
17.2
reciprocal yield 5.8%
FCF yield
-14.1%
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
-35.6%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-08-12

Profitability

9 metrics
Gross margin
—
Operating margin
-411.9%
Trailing 12 months
Net margin
-384.3%
Gross profit (TTM)
—
Operating profit (TTM)
−$318.09M
Net income (TTM)
−$296.77M
Trailing 12 months
Diluted EPS (TTM)
$-3.37
FCF margin
-152.1%
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
$0.87
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
$-3.60
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
$-3.36
Operating cash flow per diluted share (TTM)
$-1.26
Free cash flow per diluted share (TTM)
$-1.33
Capital expenditures per diluted share (TTM)
$0.06
R&D per diluted share (TTM)
$2.94
Stock compensation per diluted share (TTM)
$0.44
Book value per share
$1.98

Growth

11 metrics
Revenue growth YoY
+36.5%
Year over year
Net income growth YoY
—
Revenue (TTM)
$77.22M
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+1.4%
Year over year · more shares
Revenue CAGR (3Y)
—
Revenue CAGR (5Y)
—
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
-612.8%
Return on assets
-50.5%
Debt / equity
0.2
Current ratio
4.7
EBITDA (TTM)
—
Free cash flow (TTM)
−$117.43M
Quick ratio
4.7
Interest coverage
-224.0
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
$60.45M
Latest balance sheet
Cash & equivalents
$70.24M
Total assets
$587.79M
Total debt
$9.79M

Cash flow & spend

7 metrics
Operating cash flow (TTM)
−$111.76M
Capital expenditures (TTM)
$5.67M
R&D (TTM)
$259.47M
SG&A (TTM)
$135.28M
Stock compensation (TTM)
$38.94M
R&D / revenue
336.0%
Stock compensation / revenue
50.4%

Ownership (13F)

9 metrics
13F filers
222
13F filer change QoQ
0
Institutional ownership
98.3%
Conviction holders (share of 13F filers)
1.4%
Crowding (high-turnover and private-fund holders)
38.8%
Private-fund adviser ownership
34.8%
Active holders' share change QoQ
-0.5%
Holder tenure
15.4
Price vs estimated holder cost
+0.9%

Ownership (registered funds)

1 metrics
Index-fund ownership
17.7%

Short interest

3 metrics
Short interest
16.2%
Latest settlement · 7.7 days to cover
Days to cover
7.7d
Short-squeeze score
62 / 100

Insider activity

2 metrics
Net insider buying (90D)
$642,959
Insider-sentiment score
67 / 100

Risk flags

1 metrics
Going concern
—
Key facts CIK 1422143 CUSIP 50127T109 13F (30d) 22 filings 22 filers Visit website Investor relations